Launch week offerEnds in00h00m00s

annual Promonthly Pro

ERIDE QUARTA

Has grant

Assistant Professor,PhD

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Tissue Engineering Tissue Engineering professors in Italy

About

Dr. Eride Quarta is an Assistant Professor at Università degli Studi di Parma, Dipartimento di Scienze degli Alimenti e del Farmaco, Italy. His research focuses on inhalation therapies, particularly in the context of respiratory diseases such as cystic fibrosis and COVID-19. Recent articles of Dr. Quarta explore topics including microparticle inhalation, polyelectrolyte complex formulations, and the role of airways microbiota in health.

Recent Grants

Grant: Close

H2020-NMBP-2016-2017

Open Date:

Close Date:

Articles (21)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Daniele Catalucci

Principal Investigator

IRCCS Humanitas Research Hospital

ITALY

ERIDE QUARTA

Research Interests

Make your next move.

Explore related searches

About

Recent Grants

Articles (21)

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases

Lpb. plantarum inhalation powders for the reduction of lung inflammation and S. aureus growth control in non-CF bronchiectasis

Inhaled product dissolution as a predictive tool of drug bioavailability: a p38 MAPK inhibitor case study using Respicell® dissolution apparatus

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects

Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms

Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections

The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract

Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis

Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa

Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure

Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro

The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler

Nasal delivery as a strategy for the prevention and treatment of COVID-19

No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs

Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances

Recent Patents on Nasal Vaccines Containing Nanoadjuvants

Understanding the Importance of Capsules in Dry Powder Inhalers

Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design

Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen

Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer

Collaborators (17)

Daniele Catalucci

Francesca Buttini

Gaia Colombo

Fabio Sonvico

Leif-Hendrik Boldt

Regina Scherließ

Ruggero Bettini

benedetta bottari

VITTORIO SAMBRI

Jessica Modica

Elena Bancalari

Simona Bertoni

Federico Lavorini

Michele Iafisco

Annalisa BIANCHERA

Ben Forbes

Peter Deissler

Make your next move.